drugset / Trial / NCT04020588
Anti-inflammatories and Adolescent Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
A double-blind controlled trial assessing the efficacy of anti-inflammatories on symptoms and cognition of adolescents with schizophrenia
Timeline
- Start
- 2019-02-25
- Primary completion
- 2020-06
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | Oral |
| Comparator | Minocycline | Small molecule | 100 mg | Oral |